EA016387B1 - 2-(замещенные амино)бензотиазолсульфонамидные ингибиторы вич-протеазы - Google Patents

2-(замещенные амино)бензотиазолсульфонамидные ингибиторы вич-протеазы Download PDF

Info

Publication number
EA016387B1
EA016387B1 EA200970052A EA200970052A EA016387B1 EA 016387 B1 EA016387 B1 EA 016387B1 EA 200970052 A EA200970052 A EA 200970052A EA 200970052 A EA200970052 A EA 200970052A EA 016387 B1 EA016387 B1 EA 016387B1
Authority
EA
Eurasian Patent Office
Prior art keywords
compound
alkyl
compounds
formula
ritonavir
Prior art date
Application number
EA200970052A
Other languages
English (en)
Russian (ru)
Other versions
EA200970052A1 (ru
Inventor
Херман Аугустинус Де Кок
Тим Хьюго Мария Йонкерс
Пол Йозеф Габриел Мария Бонантс
Стефан Жюльен Ласт
Инге Диринк
Юдит Ева Баумайстер
Гербен Альберт Элэтериус Ван'Т Клостер
Original Assignee
Тиботек Фармасьютикалз Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тиботек Фармасьютикалз Лтд. filed Critical Тиботек Фармасьютикалз Лтд.
Publication of EA200970052A1 publication Critical patent/EA200970052A1/ru
Publication of EA016387B1 publication Critical patent/EA016387B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EA200970052A 2006-06-23 2007-06-22 2-(замещенные амино)бензотиазолсульфонамидные ингибиторы вич-протеазы EA016387B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06116003 2006-06-23
PCT/EP2007/056235 WO2007147884A1 (en) 2006-06-23 2007-06-22 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors

Publications (2)

Publication Number Publication Date
EA200970052A1 EA200970052A1 (ru) 2009-04-28
EA016387B1 true EA016387B1 (ru) 2012-04-30

Family

ID=37596252

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200970052A EA016387B1 (ru) 2006-06-23 2007-06-22 2-(замещенные амино)бензотиазолсульфонамидные ингибиторы вич-протеазы

Country Status (31)

Country Link
US (1) US8202887B2 (US20060241273A1-20061026-C00026.png)
EP (1) EP2035432B1 (US20060241273A1-20061026-C00026.png)
JP (1) JP5232776B2 (US20060241273A1-20061026-C00026.png)
KR (1) KR101419320B1 (US20060241273A1-20061026-C00026.png)
CN (1) CN101479275B (US20060241273A1-20061026-C00026.png)
AP (1) AP2069A (US20060241273A1-20061026-C00026.png)
AR (1) AR061619A1 (US20060241273A1-20061026-C00026.png)
AT (1) ATE544769T1 (US20060241273A1-20061026-C00026.png)
AU (1) AU2007262943B2 (US20060241273A1-20061026-C00026.png)
BR (1) BRPI0713487B1 (US20060241273A1-20061026-C00026.png)
CA (1) CA2653233C (US20060241273A1-20061026-C00026.png)
CL (1) CL2007001826A1 (US20060241273A1-20061026-C00026.png)
CY (1) CY1112971T1 (US20060241273A1-20061026-C00026.png)
DK (1) DK2035432T3 (US20060241273A1-20061026-C00026.png)
EA (1) EA016387B1 (US20060241273A1-20061026-C00026.png)
ES (1) ES2381129T3 (US20060241273A1-20061026-C00026.png)
HK (1) HK1125633A1 (US20060241273A1-20061026-C00026.png)
IL (1) IL195381A (US20060241273A1-20061026-C00026.png)
JO (1) JO2841B1 (US20060241273A1-20061026-C00026.png)
MX (1) MX2009000160A (US20060241273A1-20061026-C00026.png)
MY (1) MY146805A (US20060241273A1-20061026-C00026.png)
NZ (1) NZ573286A (US20060241273A1-20061026-C00026.png)
PE (1) PE20080342A1 (US20060241273A1-20061026-C00026.png)
PL (1) PL2035432T3 (US20060241273A1-20061026-C00026.png)
PT (1) PT2035432E (US20060241273A1-20061026-C00026.png)
SI (1) SI2035432T1 (US20060241273A1-20061026-C00026.png)
TW (1) TWI415851B (US20060241273A1-20061026-C00026.png)
UA (1) UA96445C2 (US20060241273A1-20061026-C00026.png)
UY (1) UY30416A1 (US20060241273A1-20061026-C00026.png)
WO (1) WO2007147884A1 (US20060241273A1-20061026-C00026.png)
ZA (1) ZA200810350B (US20060241273A1-20061026-C00026.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3090B1 (ar) 2009-12-11 2017-03-15 Janssen Sciences Ireland Uc 5- امينو-4- هيدروكسي-بنتويل اميدات
MX2012015097A (es) 2010-07-02 2013-05-28 Gilead Sciences Inc Derivados de acido naft-2-ilacetico para tratar sida.
TWI458711B (zh) 2010-07-02 2014-11-01 Gilead Sciences Inc 治療性化合物
US9024038B2 (en) 2010-12-27 2015-05-05 Purdue Research Foundation Compunds and methods for treating HIV
MX2013012266A (es) 2011-04-21 2013-11-22 Gilead Sciences Inc Compuestos de benzotiazol y su uso farmaceutico.
WO2013103738A1 (en) 2012-01-04 2013-07-11 Gilead Sciences, Inc. Napthalene acetic acid derivatives against hiv infection
US9376392B2 (en) 2012-01-04 2016-06-28 Gilead Sciences, Inc. 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
SG11201401189WA (en) 2012-04-20 2014-09-26 Gilead Sciences Inc Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
US12083099B2 (en) 2020-10-28 2024-09-10 Accencio LLC Methods of treating symptoms of coronavirus infection with viral protease inhibitors

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083657A2 (en) * 2001-02-14 2002-10-24 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
WO2003049746A2 (en) * 2001-12-12 2003-06-19 Tibotec Pharmaceuticals Ltd. Combination of cytochome p450 dependent protease inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1545518A1 (en) * 2002-08-02 2005-06-29 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
DE602004010291T2 (de) * 2003-09-30 2008-10-09 Tibotec Pharmaceuticals Ltd. Hcv-hemmende sulfonamide

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083657A2 (en) * 2001-02-14 2002-10-24 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
WO2003049746A2 (en) * 2001-12-12 2003-06-19 Tibotec Pharmaceuticals Ltd. Combination of cytochome p450 dependent protease inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
D.L.N.G. SURLERAUX ET AL.: "Design of HIV-1 Protease Inhibitors Active on Multidrug-Resistant Virus", JOURNAL OF MEDICINAL CHEMISTRY, vol. 48, no. 6, 2005, pages 1965-1973, XP002414592, scheme 1, compounds 20a-i; tables 2,3 *

Also Published As

Publication number Publication date
JP5232776B2 (ja) 2013-07-10
JO2841B1 (en) 2014-09-15
CL2007001826A1 (es) 2008-01-18
BRPI0713487A2 (US20060241273A1-20061026-C00026.png) 2012-11-13
BRPI0713487A8 (pt) 2018-01-02
WO2007147884A1 (en) 2007-12-27
CN101479275A (zh) 2009-07-08
EA200970052A1 (ru) 2009-04-28
JP2009541272A (ja) 2009-11-26
AR061619A1 (es) 2008-09-10
DK2035432T3 (da) 2012-05-14
EP2035432A1 (en) 2009-03-18
US20090209583A1 (en) 2009-08-20
PL2035432T3 (pl) 2012-07-31
SI2035432T1 (sl) 2012-06-29
CN101479275B (zh) 2012-03-07
HK1125633A1 (US20060241273A1-20061026-C00026.png) 2009-08-14
IL195381A0 (en) 2009-08-03
PT2035432E (pt) 2012-04-24
MX2009000160A (es) 2009-01-23
AP2069A (en) 2009-12-08
PE20080342A1 (es) 2008-04-25
CA2653233C (en) 2015-09-29
TWI415851B (zh) 2013-11-21
ATE544769T1 (de) 2012-02-15
AP2008004679A0 (en) 2008-12-31
AU2007262943A1 (en) 2007-12-27
CY1112971T1 (el) 2016-04-13
AU2007262943B2 (en) 2012-04-12
KR101419320B1 (ko) 2014-07-14
MY146805A (en) 2012-09-28
IL195381A (en) 2013-01-31
BRPI0713487B1 (pt) 2022-07-26
US8202887B2 (en) 2012-06-19
KR20090024257A (ko) 2009-03-06
CA2653233A1 (en) 2007-12-27
NZ573286A (en) 2011-09-30
ES2381129T3 (es) 2012-05-23
ZA200810350B (en) 2010-05-26
EP2035432B1 (en) 2012-02-08
UA96445C2 (ru) 2011-11-10
TW200817416A (en) 2008-04-16
UY30416A1 (es) 2008-01-31

Similar Documents

Publication Publication Date Title
EA016387B1 (ru) 2-(замещенные амино)бензотиазолсульфонамидные ингибиторы вич-протеазы
EP2632895B1 (en) Hiv protease inhibitors
EA017138B1 (ru) Замещенные аминофенилсульфонамидные соединения в качестве ингибиторов протеазы вич
EA009590B1 (ru) 2-аминобензоксазолсульфонамидные ингибиторы вич-протеазы широкого спектра
EA007383B1 (ru) 2-(замещенный амино)бензоксазолсульфонамидные ингибиторы вич-протеазы широкого спектра
EA010486B1 (ru) Замещенные оксиндолсульфонамидные ингибиторы вич-протеазы широкого спектра действия
EP2029526B1 (en) Lysine related derivatives as hiv aspartyl protease inhibitors
EA016060B1 (ru) Производные аминофенилсульфонамида в качестве ингибиторов протеазы вич
JP2008007431A (ja) 糖化蛋白形成阻害剤

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KG MD TJ TM

PC4A Registration of transfer of a eurasian patent by assignment
TC4A Change in name of a patent proprietor in a eurasian patent